Correction to: Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use
Crossref DOI link: https://doi.org/10.1007/s40267-019-00654-4
Published Online: 2019-07-18
Published Print: 2019-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Blair, Hannah A.
Lyseng-Williamson, Katherine A. http://orcid.org/0000-0002-5104-1158
Text and Data Mining valid from 2019-07-18
Version of Record valid from 2019-07-18
Article History
First Online: 18 July 2019